MaxCyte Inc at ShareSoc Webinar Transcript
I'd now like to hand over to Doug Doerfler, who is the President and CEO of MaxCyte PLC and also the Founder. Welcome to you, Doug. I believe it's morning time where you are. We look forward to hearing all about MaxCyte and I shall come back a little bit later for the Q&A.
Thank you, Karin, and thank you, everyone, for attending this update on MaxCyte and I seriously thank ShareSoc for hosting this event. Great to see so many existing shareholders of MaxCyte. Thank you for your support and I look forward to providing an update. And those of you who are new to the story, I look forward to giving you a background on the company.
MaxCyte is currently listed on London Stock Exchange, on the AIM exchange. We're also listed as of July of 2021 on the US NASDAQ. So, please refer to written documents for any forward-looking statements.
So, next slide, please. So, a little background on MaxCyte. So, we are focused in the area of cell
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |